Analysis of the impact of the MDD (Medical Device Directive) review amendments on active implants
This article was originally published in Clinica
Executive Summary
The changes proposed by the European Commission and the European Parliament to the Active Implantable Medical Device Directive (AIMDD) relating to active implantable medical devices (90/385) are more fundamental than the current proposals to revise the Medical Devices Directive (MDD - 93/42). So says vice-president of Quintiles Consulting Mika Reinikainen, who reports on the main amendments to the AIMDD proposed at the Parliament's March 29 session